Dr. Dunkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St Fl 10
Mount Sinai Faculty Practice
New York, NY 10029Phone+1 212-241-5415Fax+1 212-831-7974
Summary
- Dr. David Dunkin is a Pediatric Gastroenterology Specialist based in New York, with a subspecialty in Pediatric Inflammatory Bowel Disease Gastroenterology. His medical journey took him from obtaining a B.A. in Biology and Society at Cornell University to completing his MD at Tel Aviv University Sackler and his Residency and Fellowship at Yale-New Haven Medical Center and Icahn School of Medicine at Mount Sinai, respectively. His roles have included Associate Residency Director and Assistant Professor at Icahn School of Medicine and Director at Yale New Haven Health. His clinical experience includes eosinophilic esophagitis, pediatric inflammatory bowel disease, traditional Chinese medicine, and immune tolerance. He has authored numerous medical publications and been a part of various clinical trials. Notably, he received a Young Investigator Award from NASPGHAN in 2010 and AGA Fellow (AGAF) from the American Gastroenterological Association in 2022.
Education & Training
- Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Gastroenterology, 2006 - 2009
- Yale-New Haven Medical CenterResidency, Pediatrics, 2002 - 2005
- Tel Aviv University SacklerClass of 2002
- Cornell UniversityB.A., Biology and Society, 1992 - 1996
Certifications & Licensure
- FL State Medical License 2020 - Present
- NY State Medical License 2006 - 2026
- CT State Medical License 2005 - 2025
- NJ State Medical License 2018 - 2025
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- AGA Fellow (AGAF) American Gastroenterological Association, 2022
- Young Investigator Award NASPGHAN, 2010
- Yale/Johnson-Johnson International Health Scholar 2004
- Join now to see all
Clinical Trials
- Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease Start of enrollment: 2023 Feb 15
- A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Start of enrollment: 2020 May 18
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease Start of enrollment: 2024 Mar 13
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsAnti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.Changda Liu, David Dunkin, Joanne Lai, Ying Song, Clare Ceballos
Inflammatory Bowel Diseases. 2015-08-01 - 50 citationsDual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.Michael T. Dolinger, Elizabeth A. Spencer, Joanne Lai, David Dunkin, Marla Dubinsky
Inflammatory Bowel Diseases. 2021-07-27 - 70 citationsReal World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center.Judy R Dayan, Michael T. Dolinger, Keith J. Benkov, David Dunkin, Jacqueline Jossen
Journal of Pediatric Gastroenterology and Nutrition. 2019-07-01
Journal Articles
- A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s DiseaseDavid Dunkin ∗, Francesco Merlino ∗, Carmen Correale CEACAM5 Working Group Garabet Yeretssian, Luciana Marinelli §, Giulia Roda §, Gastroenterology, 10/2022
- Ganoderic acid C1 isolated from the Anti-asthma Formula, ASHMITM suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthm...C Liu, N Yang, Y Song, L Wang, J Zi, B Ma, D Dunkin, P Busse, W David, J Tversky, R Miller, J Zhan, XM Li, International Immunopharmacology, 1/1/2015
- Anti-inflammatory Effects of Ganoderma Lucidum Triterpenoid in Human Crohn's Disease Associated with Down-Regulation of NF-kappa B Signaling PathwayDunkin D, Liu C, Lai J, Ceballos C, Benkov K, Li XM, Inflammatory Bowel Diseases, 1/1/2015
- Join now to see all
Press Mentions
- DBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017May 8th, 2017
- Kids with Bedroom Smartphones Sleep Less: StudyJanuary 5th, 2015
- Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds - US NewsSeptember 22nd, 2014
- Join now to see all
Grant Support
- Career Development AwardCCFA2011–2014
- NIH Career Development Award (K08)NIH NIDDKPresent
Committees
- Member, NASPGHAN IBD Committee 2018 - 2021
- Member, NASPGHAN Research Committee 2012 - 2015
Professional Memberships
- Fellow
- NASPGHANMember
- CCFAMember
External Links
- IBD Centerhttp://www.mountsinai.org/ibd-center
- Mount Sinai Profilehttps://profiles.mountsinai.org/david-dunkin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: